168 related articles for article (PubMed ID: 34802573)
1. Role of MR Imaging in Head and Neck Squamous Cell Carcinoma.
Abdel Razek AAK; Elsebaie NA; Gamaleldin OA; AbdelKhalek A; Mukherji SK
Magn Reson Imaging Clin N Am; 2022 Feb; 30(1):1-18. PubMed ID: 34802573
[TBL] [Abstract][Full Text] [Related]
2. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prediction of the tumor growth rate using advanced diffusion models in head and neck squamous cell carcinoma patients.
Fujima N; Sakashita T; Homma A; Harada T; Shimizu Y; Tha KK; Kudo K; Shirato H
Oncotarget; 2017 May; 8(20):33631-33643. PubMed ID: 28430583
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
8. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
9. CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy.
Kuno H; Qureshi MM; Chapman MN; Li B; Andreu-Arasa VC; Onoue K; Truong MT; Sakai O
AJNR Am J Neuroradiol; 2017 Dec; 38(12):2334-2340. PubMed ID: 29025727
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
Martens RM; Noij DP; Ali M; Koopman T; Marcus JT; Vergeer MR; de Vet H; de Jong MC; Leemans CR; Hoekstra OS; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Oral Oncol; 2019 Jan; 88():75-83. PubMed ID: 30616800
[TBL] [Abstract][Full Text] [Related]
11. Postoperative and postradiation head and neck: role of magnetic resonance imaging.
Moore AG; Srinivasan A
Top Magn Reson Imaging; 2015 Feb; 24(1):3-13. PubMed ID: 25654417
[TBL] [Abstract][Full Text] [Related]
12. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
[TBL] [Abstract][Full Text] [Related]
13. Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI.
Lee JY; Cheng KL; Lee JH; Choi YJ; Kim HW; Sung YS; Chung SR; Ryu KH; Chung MS; Kim SY; Lee SW; Baek JH
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1392-1401. PubMed ID: 31320461
[TBL] [Abstract][Full Text] [Related]
14. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
Nagasaka M; Zaki M; Issa M; Kim H; Abrams J; Sukari A
Laryngoscope; 2017 Oct; 127(10):2260-2264. PubMed ID: 28271529
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
16. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
17.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor imaging in differentiation of residual head and neck squamous cell carcinoma from post-radiation changes.
Abdel Razek AAK
Magn Reson Imaging; 2018 Dec; 54():84-89. PubMed ID: 30142392
[TBL] [Abstract][Full Text] [Related]
19. The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Terada H; Shimode Y; Furukawa M; Sato Y; Hanai N
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33922457
[No Abstract] [Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
